9,10-dimethyl-1,2-benzanthracene has been researched along with Cancer, Second Primary in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aromando, RF; Blaumann, H; Calzetta, O; Heber, EM; Itoiz, ME; Longhino, J; Monti Hughes, A; Nievas, SI; Nigg, DW; Pozzi, E; Schwint, AE; Trivillin, VA | 1 |
Fujiwara, K; Igarashi, J; Irahara, N; Kimura, M; Nagase, H | 1 |
2 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and Cancer, Second Primary
Article | Year |
---|---|
Boron neutron capture therapy (BNCT) inhibits tumor development from precancerous tissue: an experimental study that supports a potential new application of BNCT.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Borohydrides; Boron Compounds; Boron Neutron Capture Therapy; Cricetinae; Mouth Neoplasms; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Phenylalanine; Precancerous Conditions; Radiation-Sensitizing Agents; Sulfhydryl Compounds; Tissue Distribution | 2009 |
New chemically induced skin tumour susceptibility loci identified in a mouse backcross between FVB and dominant resistant PWK.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Chromosome Mapping; Crosses, Genetic; Drug Resistance; Female; Genes, Dominant; Genetic Linkage; Genetic Predisposition to Disease; Genotype; Male; Mice; Mice, Inbred Strains; Neoplasms, Second Primary; Papilloma; Quantitative Trait Loci; Skin Neoplasms; Tetradecanoylphorbol Acetate | 2007 |